DOC's Q3 report is due on February 12th. While FX and IAS29 (hyperinflation treatment) should negatively impact reported Q3 numbers, fx-adj. growth should remain strong.
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
DOC's Q3 report is due on February 12th. While FX and IAS29 (hyperinflation treatment) should negatively impact reported Q3 numbers, fx-adj. growth should remain strong.
